Arachidonic acid and lipoxin A4 attenuate alloxan- induced cytotoxicity to RIN5F cells in vitro and type 1 diabetes mellitus in vivo
Arachidonic acid and lipoxin A4 attenuate alloxan- induced cytotoxicity to RIN5F cells in vitro and type 1 diabetes mellitus in vivo
复制标题
DOI:
10.1002/biof.1336
复制
发表时间:
2017-03-01
期刊:
影响因子:
6
通讯作者:
Das, Undurti N.
中科院分区:
文献类型:
--
作者:
Gundala, Naveen K. V.;Naidu, Vegi G. M.;Das, Undurti N.
Objective: We studied whether polyunsaturated fatty acids (PUFAs) can protect rat insulinoma (RIN5F) cells against alloxan-induced apoptosis in vitro and type 1 diabetes mellitus (type 1 DM) in vivo and if so, mechanism of this beneficial action. Material and Methods: In vitro study was conducted using RIN5F cells while in vivo study was performed in Wistar rats. The effect of PUFAs, cyclo-oxygenase and lipoxygenase inhibitors, various eicosanoids and PUFAs metabolites: lipoxin A4 (LXA4), resolvin D2 and protectin against alloxan-induced cytotoxicity to RIN5F cells and type 1 DM was studied. Expression of PDX1, P65 NF-kB and IKB in RIN5F cells and Nrf2, GLUT2, COX2, iNOS protein levels in the pancreatic tissue and plasma glucose, insulin and tumor necrosis factor-a and antioxidants, lipid peroxides and nitric oxide were measured. Results: Of all, arachidonic acid ( AA) was found to be the most effective against alloxan-induced cytotoxicity to RIN5F cells and preventing type 1 DM. Both cyclo-oxygenase and lipoxygenase inhibitors did not block the beneficial actions of AA in vitro and in vivo. Alloxan inhibited LXA4 production by RIN5F cells and in alloxan-induced type 1 DM Wistar rats. AA-treatment restored LXA4 levels to normal both in vitro and in vivo. LXA4 protected RIN5F cells against alloxan-induced cytotoxicity and prevented type 1 DM and restored expression of Nrf2, Glut2, COX2, and iNOS genes and abnormal antioxidants to near normal. Discussion: AA seems to bring about its beneficial actions against alloxan-induced cytotoxicity and type 1 DM by enhancing the production of LXA4. (C) 2016